Minoxidil Response Testing in Females With Female Pattern Hair Loss

• Status: Completed
• Trial end date: 2018-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

The primary purpose of this study is to evaluate the clinical validity of the minoxidil response in-vitro diagnostic kit.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Applied Biology, Inc.
• Treatments: Minoxidil

Criteria

Inclusion Criteria:

• Females in overall good health

• Age: 18 or older

• Female pattern hair loss

• Willing to have a mini dot tattoo placed in the target area of the scalp

• Willing to maintain the same hair style, color, shampoo and hair products use, and approximate hair length throughout the study

• Able to give informed consent

• Able to comply with the study requirements for 24 consecutive weeks

• Willing to use an adequate method of birth control (if applicable)

• Negative urine pregnancy test

Exclusion Criteria:

• Previous adverse event from topical minoxidil treatment

• History of hypotension

• Uncontrolled hypertension

• Pregnant, nursing, or planning a pregnancy during the study

• Prior hair transplant

• Uses wigs or hair weaves

• Have used minoxidil (topical or oral) anytime during the past 6 months

• Chronic scalp disorders that require medications

• Uses medication known to cause hair thinning such as Coumadin and anti-depressants/anti-psychotics

• Folliculitis

• Scalp psoriasis

• Seborrheic dermatitis

• Inflammatory scalp conditions such as lichen planopilaris

• Enrolled in any other medical study or has been enrolled in any medical study in the past 6 months